Addiction Treatment Market 2024-2032: Global Industry Analysis, Share, Size, Growth and Forecast

The latest report by IMARC Group, titled “Addiction Treatment Market Report by Treatment Type (Medications, Counselling and Behavioural Therapies, and Others), Addiction Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatments, and Others), Treatment Center (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers), and Region 2024-2032“, The global addiction treatment market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.76% during 2024-2032.

Addiction treatment involves various methods to assist people in overcoming substance dependence or behavioral issues that hinder their regular functioning. These methods include medical detox, counseling, medication support, and ongoing care to support sobriety and overall health. Typically provided in specialized facilities, these interventions utilize a team of experts, such as psychiatrists and counselors, to address both the physical and mental aspects of addiction. The shift towards individualized and evidence-based treatments reflects a dedication to more efficient and compassionate approaches within the field. Current addiction treatment focuses on prompt detoxification and tackling underlying triggers to lessen relapse occurrences and enhance life quality.

Addiction Treatment Market Trends and Drivers:

The global addiction treatment market is experiencing significant growth due to several factors, including the increasing prevalence of substance abuse and the expanding awareness of available treatment options. Supportive regulatory policies, particularly in developed countries, are also contributing to the market's growth, as they aim to address the opioid crisis. The rise in government and private funding for addiction treatment research is leading to the development of innovative and effective treatment methods, further propelling the market. Moreover, the COVID-19 pandemic has accelerated the adoption of telehealth services, making remote addiction treatment more accessible and convenient, thereby fueling market growth. Additionally, the growing emphasis on mental health in the workplace is prompting employers to include addiction treatment in employee wellness programs, which is also supporting the market's expansion.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/addiction-treatment-market/requestsample

The report has segmented the market into the following categories:

Breakup by Treatment Type:

• Medications
  • Bupropion
  • Varenicline
  • Acamprosate
  • Disulfiram
  • Naltrexone
  • Methadone
  • Buprenorphine
  • Nicotine Replacement Products
  • Others
• Counselling and Behavioural Therapies
  • Cognitive-Behavioural Therapy
  • Multi-Dimensional Therapy
  • Motivational
  • Others
• Others

Breakup by Addiction Type:

• Alcohol Addiction Treatment
• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatments
• Others

Breakup by Treatment Center:

• Outpatient Treatment Centers
• Residential Treatment Centers
• Inpatient Treatment Centers 

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• Alkermes plc
• Dr. Reddy’s Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Indivior PLC
• Mallinckrodt Pharmaceuticals
• Orexo AB
• Pear Therapeutics (US) Inc.
• Pfizer Inc.
• Viatris Inc.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145